Recently, Lu and colleagues developed a novel clinical and data analysis procedure based on sequential tape stripping with TEWL measurement and SC protein analysis, in the course of a study investigating the SC barrier and the hygroscopic properties of normal and cosmetic dry skin. This pro cedure was thought to be a more robust method than those previously used for SC barrier analysis. 3 BuildingonthefindingsofLuetal, 3 the present study explored two different clinical methods of assessing the effect of a moisturizing product on SC barrier repair in female subjects with dry skin, with the objective of identifying an assessment method for accelerated barrier repair for use in future studies.
| MATERIAL S AND ME THODS

| Study design
This was a single-cen tre, non -rand omized, split-body study to explore two clinical meth ods of a ssessi ng SC barrier repair, using a marketed cosmetic moisturizer (Curel, a registered trademark of Kao Corporation, Tokyo, Japan) containing glycerine, isopropyl palmitate, petrolatum, and Butyro spermum parkii (shea) butter in female subjects with dry skin. The primary objective was to identify an accelerated method of assessing SC barrier repair. The study was conducted between8Apriland22May2015atasinglecentreinIrving,TX, USA,inaccordancewithapplicablelocalethicalandregulatoryrequirements.Allsubjectsprovidedwritteninformedconsent.
| Subjects
Eligiblesubjectswerehealthyfemal eCaucasians,aged≥18years, 
| Methods and assessments
Eligible subjects underwent a 7-day washout period, using only the provided soap to cleanse the lower legs (Ivory® Original; Procter & Gamble, Cincinnati, OH, USA). This soap was used from screening until study completion.
The intervention included two methods that were defined as method A and method B. A subject's right lower leg was used for methodA,andasubject'sleftlowerlegwasusedformethodB.For both methods, subject visits/assessments took place at baseline and onDays3,5,7,10,12and14.
At the baseline visit (Day 0), the outer aspects of a subject's lower legs were each marked into an upper test area to be treated with moisturizer and a lower test area to be left untreated.
FormethodA,sevensmallareasweremarkedontheupperarea (#1-7) and seven on the lower area (#8-14) where stripping (using Transepidermal water loss assessments for this study were performed using the Tewameter® TM 300 (Courage+Khazaka electronic GmbH, Cologne, Germany) device. D-Squame disc protein mass was measured using the SquameScan® 850 (Heiland electronic GmbH, Wetzlar, Germany). Safety was assessed throughout thestudybymonitoringofadverseevents(AEs).
| Statistical analyses
AsdescribedinthemethodofLuetal, 3 the relative barrier quality among the subjects (or subject groups) can be obtained by comparing the slopes of the regression of the 1/TEWL vs cumulative protein (Cp) removed for each subject (or subject group). The relative SC thickness can be determined from the values of Cp removal that can be quantified according to where the regression lines intercept the x-axis. It was planned to recruit 25 subjects so that at least 20 evaluable subjects would complete the study. With 20 subjects, the study had 90% power to show a difference between treated and untreated groups of 32% in SC barrier quality and 22% in SC thickness.
This assumed a standard deviation of the paired differences (treated Cumulative protein removed (%) the change in TEWL value from pre-to post-stripping (after removal of 20 strips) was calculated and compared between treated anduntreatedareas.Arepeatedmeasuresmodelwasfittedwith factors for treatment, day and treatment*day (fixed effects), and subject (random effect), and a covariate for change from pre-to post-stripped TEWL assessed at baseline.
For method B, the change in TEWL value from post-stripping at baseline to each subsequent visit was calculated and compared
betweentreatedanduntreatedareas.Arepeatedmeasuresmodel
(analysis model 1) was fitted with factors for treatment, day and treatment*day (fixed effects), and subject (random effect), and covariates for pre-and post-stripped TEWL (both measured at baseline).Analternativeexploratorymodel(analysismodel2)wasfitted using only a single covariate of change from pre-to post-stripped TEWL assessed at baseline.
| RE SULTS AND D ISCUSS I ON
| Subjects
Of28subjectsscreened,24participatedinthestudyandwerein-cludedintheintent-to-treatandsafetypopulations.Allwerefemale, Caucasian,andhadalegdrynessgradingatbaselineof≥2.Themean (standard deviation) age was 39.6 (9.87) years and the age range was 20-55 years.
| Method A
The mean slope values of plots of 1/TEWL vs Cp decreased over time for both treated and untreated areas, indicating an improvement in SC barrier quality ( Figure 1 and Figure 2) . Slope values were not significantly different between treated and untreated areas at any time; however, a trend was observed for values of treated areas to be morenegativethanuntreatedareasbyDay14(P = 0.082) ( Table 1a ).
The total amount of protein removed by tape stripping on untreated areas was higher than for the treated areas (with statistically significant differencesseenatDays7,12and14;Table1b).Thiscouldpossiblybe attributable to the fact that moisturization improves the skin dryness, which could therefore reduce the amount of cells (proteins) taken off duringstripping.ValuesforchangeinTEWLfrompre-topost-stripping
were not significantly different between treated and untreated areas at anyvisit,andnotrendwasobserved(Table1candFigure3A).Values for change in TEWL from pre-stripping at baseline to pre-stripping at each visit were generally not significantly different over the course of thestudyforbothtreatedanduntreatedareas(Table1dandFigure3B).
These findings suggest that the moisturizer treatment did not produce physiological improvement in the SC barrier under the conditions of this study.
| Method B
Transepidermal water loss values for both treated and untreated areas decreased over time from the post-stripping value at baseline, indicatingimprovedSCbarrierrepair.Analysismodel1,usingboth pre-and post-stripping TEWL baseline values as covariates, generally showed no significant difference between treated and untreated areas. The TEWL values for treated and untreated areas decreased to a similar extent over the study period, demonstrating that both areas eventually return to values measured at baseline (Table 2a and 
| Safety
One AE of dermatitis following contact with poison ivy was reported; this was mild and not considered to be related to the study product.NoseriousAEswerereported.
| CON CLUS IONS
Although the study by Lu and colleagues demonstrated a method that was thought to be more robust than those previously used for SC barrier analysis, 3 the present investigation did not manage to secure a significant exploratory method for the purposes of accelerated repair. 
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